Subchronic cocaine selectively increased striatonigral dynorphin through a dopaminergic mechanism requiring both D1 and D2 receptors — enkephalin and substance P were unchanged.
Selective dynorphin increaseCocaine raised only dynorphin via D1+D2 dopamine — other peptides unchanged
What the researchers found
Subchronic cocaine selectively increased striatonigral dynorphin through a dopaminergic mechanism requiring both D1 and D2 receptors. Enkephalin and substance P were unaffected.
Why it matters
Dynorphin increases may represent the brain's attempt to counteract cocaine's rewarding effects. This compensatory response could contribute to withdrawal symptoms and tolerance.
How the study worked
Rats received cocaine (20 mg/kg/day for 4 days). Brain peptide levels were measured by radioimmunoassay. Dopamine involvement was confirmed using 6-OHDA lesions and D1/D2 antagonists.
What this study cannot tell us
Animal study using a relatively short cocaine regimen. Human cocaine use patterns are more variable. The functional consequences of elevated dynorphin were not directly tested.
How to read the evidence
Preliminary animal study with good controls (6-OHDA lesions, selective antagonists).
When this study was published
Published in 1989 — established the cocaine-dynorphin connection in addiction neuroscience.
The bigger picture
Cocaine selectively rewiring the dynorphin system may be a compensatory response — dynorphin generally produces dysphoria (unpleasant feelings), which could serve as a natural brake on cocaine reward.
Questions still open
- Does dynorphin increase contribute to cocaine crash and dysphoria?
- Could dynorphin-targeting drugs treat cocaine addiction?
Common questions
Why does cocaine increase dynorphin?
Is dynorphin increase good or bad?
Read the original research
Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
The Journal of pharmacology and experimental therapeutics, 250(3), 818-24
Citation
Sivam, S P. (1989). Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.. The Journal of pharmacology and experimental therapeutics, 250(3), 818-24.